Vertex Global HC Fund II Pte. Ltd. - Jun 24, 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role: 10%+ Owner
Signature: /s/ Wing Shing Lee, Attorney-in-Fact
Stock symbol: ELEV
Transactions as of: Jun 24, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/24/2021, 06:33 PM
Next filing: Jun 29, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ELEV	Series A Convertible Preferred Stock							Jun 24, 2021	Common Stock	1.66M		Direct	F1
holding	ELEV	Series B Convertible Preferred Stock							Jun 24, 2021	Common Stock	401K		Direct	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock will automatically convert into Common Stock immediately on a 4.225582-for-one basis (4.225582 shares of preferred stock will convert into 1 share of Common Stock) prior to the closing of the Issuer's initial public offering, and has no expiration date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney